Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (21-30 of 300) with videos related to

Pageof 30
Sort By:
HIV Clinical Trials|February 11, 2009
Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patientsMarta Boffito, Diego Miralles, Andrew Hill
Current Opinion in Infectious Diseases|June 18, 2009
Drug-drug interactions involving new antiretroviral drugs and drug classesJesse Soodalter, Marta Sousa, Marta Boffito
The Journal of Antimicrobial Chemotherapy|August 21, 2008
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugsMarta Sousa, Anton Pozniak, Marta Boffito
Current Opinion in HIV and AIDS|June 2, 2017
Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countriesKay Seden, Marta Boffito, Saye Khoo
Journal of Clinical Pharmacology|January 25, 2006
Practical perspectives on the use of tipranavir in combination with other medications: lessons learned from pharmacokinetic studiesMarta Boffito, Desmond Maitland, Anton Pozniak
AIDS (London, England)|November 7, 2015
Twenty years of boosting antiretroviral agents: where are we today?Marta Boffito, David Back, José M Gatell
BMJ (Clinical Research Ed.)|March 14, 2019
Guidelines in the context of medical ethicsLaura J Waters, Simon Collins, Marta Boffito
BMJ (Clinical Research Ed.)|October 31, 2015
Unexpected rapid weight gain in a patient with HIV and anorexiaMalika Mohabeer Hart, Marta Boffito, Anton Pozniak
Current Opinion in HIV and AIDS|April 14, 2017
Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settingsGary Maartens, Marta Boffito, Charles W Flexner
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2016
Critical Review: What Dose of Rifabutin Is Recommended With Antiretroviral Therapy?H Manisha Yapa, Marta Boffito, Anton Pozniak
Pageof 30

Showing results (21-30 of 300) with videos related to

Sort By:
Pageof 30
HIV Clinical Trials|February 11, 2009
Pharmacokinetics, efficacy, and safety of darunavir/ritonavir 800/100 mg once-daily in treatment-naïve and -experienced patientsMarta Boffito, Diego Miralles, Andrew Hill
Current Opinion in Infectious Diseases|June 18, 2009
Drug-drug interactions involving new antiretroviral drugs and drug classesJesse Soodalter, Marta Sousa, Marta Boffito
The Journal of Antimicrobial Chemotherapy|August 21, 2008
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugsMarta Sousa, Anton Pozniak, Marta Boffito
Current Opinion in HIV and AIDS|June 2, 2017
Drug interactions and the role of pharmacokinetic trials in guiding choices in first-line HIV therapy in low-income and middle-income countriesKay Seden, Marta Boffito, Saye Khoo
Journal of Clinical Pharmacology|January 25, 2006
Practical perspectives on the use of tipranavir in combination with other medications: lessons learned from pharmacokinetic studiesMarta Boffito, Desmond Maitland, Anton Pozniak
AIDS (London, England)|November 7, 2015
Twenty years of boosting antiretroviral agents: where are we today?Marta Boffito, David Back, José M Gatell
BMJ (Clinical Research Ed.)|March 14, 2019
Guidelines in the context of medical ethicsLaura J Waters, Simon Collins, Marta Boffito
BMJ (Clinical Research Ed.)|October 31, 2015
Unexpected rapid weight gain in a patient with HIV and anorexiaMalika Mohabeer Hart, Marta Boffito, Anton Pozniak
Current Opinion in HIV and AIDS|April 14, 2017
Compatibility of next-generation first-line antiretrovirals with rifampicin-based antituberculosis therapy in resource limited settingsGary Maartens, Marta Boffito, Charles W Flexner
Journal of Acquired Immune Deficiency Syndromes (1999)|February 9, 2016
Critical Review: What Dose of Rifabutin Is Recommended With Antiretroviral Therapy?H Manisha Yapa, Marta Boffito, Anton Pozniak
Pageof 30